506 related articles for article (PubMed ID: 20484178)
1. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
; Zisman DA; Schwarz M; Anstrom KJ; Collard HR; Flaherty KR; Hunninghake GW
N Engl J Med; 2010 Aug; 363(7):620-8. PubMed ID: 20484178
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis.
Jackson RM; Glassberg MK; Ramos CF; Bejarano PA; Butrous G; Gómez-Marín O
Lung; 2010 Apr; 188(2):115-23. PubMed ID: 20012639
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.
Han MK; Bach DS; Hagan PG; Yow E; Flaherty KR; Toews GB; Anstrom KJ; Martinez FJ;
Chest; 2013 Jun; 143(6):1699-1708. PubMed ID: 23732584
[TBL] [Abstract][Full Text] [Related]
4. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial.
Lederer DJ; Bartels MN; Schluger NW; Brogan F; Jellen P; Thomashow BM; Kawut SM
COPD; 2012 Jun; 9(3):268-75. PubMed ID: 22360383
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil in idiopathic pulmonary fibrosis.
Mubarak K
N Engl J Med; 2010 Nov; 363(22):2170; author reply 2170-1. PubMed ID: 21105802
[No Abstract] [Full Text] [Related]
7. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
[TBL] [Abstract][Full Text] [Related]
8. Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
Kolb M; Raghu G; Wells AU; Behr J; Richeldi L; Schinzel B; Quaresma M; Stowasser S; Martinez FJ;
N Engl J Med; 2018 Nov; 379(18):1722-1731. PubMed ID: 30220235
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
Behr J; Nathan SD; Harari S; Wuyts W; Kirchgaessler KU; Bengus M; Gilberg F; Wells AU
Respir Med; 2018 May; 138():13-20. PubMed ID: 29724385
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension.
Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P
J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526
[TBL] [Abstract][Full Text] [Related]
13. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.
Swigris JJ; Streiner DL; Brown KK; Belkin A; Green KE; Wamboldt FS;
Respir Med; 2014 Jan; 108(1):181-8. PubMed ID: 24388667
[TBL] [Abstract][Full Text] [Related]
14. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
[TBL] [Abstract][Full Text] [Related]
15. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ
J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J; Nathan SD; Wuyts WA; Mogulkoc Bishop N; Bouros DE; Antoniou K; Guiot J; Kramer MR; Kirchgaessler KU; Bengus M; Gilberg F; Perjesi A; Harari S; Wells AU
Lancet Respir Med; 2021 Jan; 9(1):85-95. PubMed ID: 32822614
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil in idiopathic pulmonary fibrosis.
Maher TM
N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
[No Abstract] [Full Text] [Related]
19. A phase III, multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension.
Satoh T; Saji T; Watanabe H; Ogawa S; Takehara K; Tanabe N; Yamada N; Yao A; Miyaji K; Nakanishi N; Suzuki Y; Fujiwara T; Kuriyama T
Circ J; 2011; 75(3):677-82. PubMed ID: 21304214
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil: a review of its use in pulmonary arterial hypertension.
Croom KF; Curran MP
Drugs; 2008; 68(3):383-97. PubMed ID: 18257613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
